argenx SE | Results Presentation Deck | 20 slides

argenx · 2021-03
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

20
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Humble Origins
02
front_matter
Open slide detailBeat · Humble Origins
03
summarize
Open slide detailBeat · Humble Origins
04
Uses a biological process diagram to explain mechanism of action.present_framework
Open slide detailBeat · Rising SuccessLoop · Before After
05
The slide combines clinical data points with human-centric patient stories to build credibility.illustrate_case
Open slide detailBeat · Rising SuccessLoop · Before After
06
The slide uses a series of four big-number metrics to communicate clinical efficacy.summarize
Open slide detailBeat · Rising Success
07
The chart shows a positive correlation between IgG reduction and clinical improvement in MG-ADL scores.present_solution
Open slide detailBeat · Rising Success
08
The slide outlines a multi-stage clinical trial process including a Go/No Go decision point.present_framework
Open slide detailBeat · Rising SuccessLoop · Quick Win Big Bet
09
The slide outlines the dosing schedule (weeks 1-4, 5-16, and beyond) and the primary objective for the trials.present_framework
Open slide detailBeat · Rising SuccessLoop · Quick Win Big Bet
10
The slide uses a process flow diagram to illustrate the clinical trial protocol.present_framework
Open slide detailBeat · Rising SuccessLoop · Quick Win Big Bet
11
The slide uses a flow-based diagram to map disease indications to franchises, using checkmarks to indicate proof-of-concept.present_solution
12
The slide uses a biological pathway diagram to illustrate the mechanism of action.present_solution
13
The slide compares CR and CRc rates for ITT and patients with >= 2 cycles, while noting 30-day mortality and adverse risk classification.summarize
14
The diagram uses a hub-and-spoke model to represent the flow of innovation.present_framework
15
The table displays revenue, operating expenses, operating loss, and net loss figures in thousands of Euros.analyze_data
16
The slide uses a three-column layout to present different community-facing assets.other
17
The slide uses a split-screen layout to contrast US regulatory progress with global (Japan, EU, China) filing expectations.establish_context
18
The slide uses a circular, interconnected diagram to show the pillars of the launch strategy.present_solution
19
Uses a funnel-like arrow diagram to represent growth in indications. Includes a legend for therapeutic areas (Neuro, Heme, Skin, Kidney).present_framework
Open slide detailBeat · Ultimate Achievement
20
The slide uses a hub-and-spoke diagram to present strategic priorities.prioritize
Open slide detailBeat · Ultimate Achievement